Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kmart restructuring

This article was originally published in The Tan Sheet

Executive Summary

Gregg Treadway appointed exec VP-store operations, will head new field organizational structure effective immediately, retailer announces Feb. 5. Formerly senior VP-Midwest division, Treadway will report to CEO Chuck Conaway. Kmart's new structure includes five operating divisions - four geographical regions and one "super center" - rather than six geographical field locations. Newly appointed division presidents report to Treadway. Move is first step toward reorganization since Kmart filed for Chapter 11 protection Jan. 22 (1"The Tan Sheet" Jan. 28, 2002, p. 9)...

You may also be interested in...



Kmart Reorganization Effort Backed With $2 Bil. Loan

Kmart will finance a "fast-tracked" reorganization effort under Chapter 11 bankruptcy protection with a $2 bil. financing facility, the Troy, Mich. retailer announced Jan. 22

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093633

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel